Home › Funds › Edge Wealth Management LLC › ADPT
Edge Wealth Management LLC position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Edge Wealth Management LLC reported holding 87,000 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.38% of its reported portfolio and ranking #31 among its reported holdings. Edge Wealth Management LLC has disclosed ADPT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How Edge Wealth Management LLC's ADPT position evolved
Edge Wealth Management LLC first disclosed a stake in ADPT in Q3 2023 at 90,000 shares (US$490K). The position peaked in Q3 2026 at 87,000 shares, worth US$2.5M. Across 13 filings, Edge Wealth Management LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 87,000 shares valued at US$2.5M — a reduction of -3,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 90.00K | $490.50K | New |
| Q4 2023 | 90.00K | $441.00K | Hold |
| Q1 2024 | 90.00K | $288.90K | Hold |
| Q2 2024 | 90.00K | $325.80K | Hold |
| Q3 2024 | 90.00K | $460.80K | Hold |
| Q4 2024 | 90.00K | $539.55K | Hold |
| Q1 2025 | 90.00K | $668.70K | Hold |
| Q2 2025 | 90.00K | $1.05M | Hold |
| Q3 2025 | 90.00K | $1.35M | Hold |
| Q4 2025 | 90.00K | $1.46M | Hold |
| Q1 2026 | 90.00K | $1.25M | Hold |
| Q2 2026 | 90.00K | $1.93M | Hold |
| Q3 2026 | 87.00K | $2.53M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ADPT and 13F data
ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 53 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M sh · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M sh · $39.44M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M sh · $26.11M · Q2 2026
- Blue Water Life Science Advisors, LP 1.01M sh · $21.67M · Q2 2026
- Granite Investment Partners, LLC 757.22K sh · $16.24M · Q2 2026
More on Edge Wealth Management LLC
FAQ
How long has Edge Wealth Management LLC held ADPT?
Edge Wealth Management LLC has disclosed ADPT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Edge Wealth Management LLC's current position in ADPT?
As of Q3 2026, Edge Wealth Management LLC holds 87.00K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $2.53M, representing 0.38% of its reported portfolio and ranking #31.
Has Edge Wealth Management LLC been buying or selling ADPT?
In the latest 13F filing (Q3 2026), Edge Wealth Management LLC reduced its position in ADPT. The position peaked in Q3 2026 at 87.00K shares.
Which other funds hold ADPT?
Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.